|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS: | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Due from Sponsor | |||||||
| Total current assets | |||||||
| Prepaid expenses non-current | |||||||
| Marketable securities held in Trust Account | |||||||
| Total Assets | |||||||
| LIABILITIES, REDEEMABLE ORDINARY SHARES AND STAREHOLDERS’ DEFICIT: | |||||||
| Accrued offering costs and expenses | |||||||
| Due to related party | |||||||
| Total current liabilities | |||||||
| Warrant liability | |||||||
| Deferred underwriting commissions | |||||||
| Total liabilities | |||||||
| Class A ordinary shares subject to possible redemption, 27,600,000 shares at redemption value at September 30, 2022 and December 31, 2021 | |||||||
| Shareholders’ Deficit: | |||||||
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued and outstanding (excluding 27,600,000 shares subject to possible redemption) | |||||||
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 6,900,000 shares issued and outstanding at September 30, 2022 and December 31, 2021 | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total shareholders’ deficit | |||||||
| Total Liabilities, Redeemable Ordinary Shares and Shareholders’ Deficit |
Loading...